Welch Group, LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 918 filers reported holding NOVARTIS A G in Q3 2015. The put-call ratio across all filers is 1.29 and the average weighting 0.6%.

Quarter-by-quarter ownership
Welch Group, LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$1,110,784
-6.7%
10,905
-7.5%
0.07%
-2.9%
Q2 2023$1,190,032
+9.7%
11,7930.0%0.07%
+7.9%
Q1 2023$1,084,956
-8.8%
11,793
-10.0%
0.06%
-7.4%
Q4 2022$1,189,248
+15.5%
13,109
-3.3%
0.07%
+1.5%
Q3 2022$1,030,000
-10.1%
13,5570.0%0.07%
-4.3%
Q2 2022$1,146,000
-12.6%
13,557
-9.3%
0.07%
-6.7%
Q1 2022$1,311,000
-9.7%
14,941
-10.0%
0.08%
-11.8%
Q4 2021$1,452,000
-29.5%
16,605
-34.0%
0.08%
-38.8%
Q3 2021$2,059,000
-94.1%
25,176
-93.4%
0.14%
-94.1%
Q2 2021$34,654,000
+11.4%
379,811
+4.4%
2.36%
+5.6%
Q1 2021$31,095,000
-8.4%
363,764
+1.1%
2.24%
-17.8%
Q4 2020$33,961,000
+10.0%
359,640
+1.3%
2.72%
+1.0%
Q3 2020$30,863,000
+2.3%
354,914
+2.7%
2.70%
-4.4%
Q2 2020$30,170,000
+6.8%
345,429
+0.8%
2.82%
-6.4%
Q1 2020$28,241,000
-8.9%
342,518
+4.6%
3.01%
-1.2%
Q4 2019$31,009,000
+10.0%
327,478
+1.0%
3.05%
+5.4%
Q3 2019$28,187,000
-7.0%
324,360
-2.3%
2.90%
-10.5%
Q2 2019$30,312,000
+7.3%
331,968
+13.0%
3.24%
+4.0%
Q1 2019$28,256,000
+11.4%
293,900
-0.6%
3.11%
+0.1%
Q4 2018$25,369,000
+0.8%
295,647
+1.2%
3.11%
+18.5%
Q3 2018$25,176,000
+17.2%
292,205
+2.7%
2.62%
-2.0%
Q2 2018$21,483,000
-3.2%
284,389
+3.6%
2.68%
-4.8%
Q1 2018$22,200,000
+29.5%
274,588
+34.5%
2.81%
+5.7%
Q4 2017$17,144,000
-3.5%
204,187
-1.3%
2.66%
-10.4%
Q3 2017$17,761,000
+3.2%
206,885
+0.4%
2.97%
+3.4%
Q2 2017$17,206,000
+22.2%
206,130
+8.7%
2.87%
+8.3%
Q1 2017$14,079,000
+15.1%
189,563
+12.9%
2.65%
+10.8%
Q4 2016$12,234,000
-8.5%
167,956
-0.8%
2.39%
-10.0%
Q3 2016$13,370,000
+2.3%
169,323
+6.9%
2.66%
-0.1%
Q2 2016$13,064,000
-3.2%
158,338
-15.0%
2.66%
+18.0%
Q1 2016$13,500,000
-6.9%
186,356
+10.5%
2.25%
-13.5%
Q4 2015$14,507,000
-4.3%
168,607
+2.2%
2.60%
-11.1%
Q3 2015$15,160,000
-4.2%
164,916
+2.5%
2.93%
-2.2%
Q2 2015$15,823,000
-0.7%
160,904
-0.4%
3.00%
+2.4%
Q1 2015$15,936,000
+7.9%
161,610
+1.3%
2.93%
+2.7%
Q4 2014$14,776,000
+0.2%
159,463
+1.8%
2.85%
-6.5%
Q3 2014$14,741,000
+4.7%
156,594
+0.6%
3.05%
+4.5%
Q2 2014$14,086,000
+7.0%
155,595
+0.5%
2.92%
-2.1%
Q1 2014$13,163,000
+4.4%
154,817
-1.3%
2.98%
+4.3%
Q4 2013$12,607,000
+6.0%
156,840
+1.1%
2.86%
-2.3%
Q3 2013$11,899,000
+11.2%
155,114
+2.5%
2.92%
+5.3%
Q2 2013$10,700,000151,3242.78%
Other shareholders
NOVARTIS A G shareholders Q3 2015
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders